MDxHealth (MDXH) director Koen Hoffman awarded 10,000 share options via Ahok BV

Rhea-AI Filing Summary

Hoffman Koen reported acquisition or exercise transactions in this Form 4 filing.

MDxHealth SA director Koen Hoffman reported a compensation-related grant of share options held indirectly through Ahok BV. The award covers 10,000 options, each exercisable into one ordinary share at $0.76 per share, expiring on May 28, 2036.

The options were granted on June 1, 2026 and vest in full on the date of the annual general shareholders' meeting held in the calendar year after the grant year. The options are held by Ahok BV, of which Hoffman owns 53.33%, and he disclaims beneficial ownership beyond any pecuniary interest.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hoffman Koen

Role null

Type	Security	Shares	Price	Value
Grant/Award	Share Option	10,000	$0.00	--

Holdings After Transaction: Share Option — 10,000 shares (Indirect, By Ahok BV)

Footnotes (1)

1. Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $0.76 granted on June 1, 2026 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted. Share Options held by Ahok BV may be deemed to be beneficially owned by the Reporting Person as the owner of 53.33% of Ahok BV. The Reporting Person disclaims beneficial ownership of the securities held by Ahok BV other than to the extent that he may have a pecuniary interest therein.

Key Figures

Options granted: 10,000 options Exercise price: $0.76 per share Expiration date: May 28, 2036 +2 more

5 metrics

Options granted 10,000 options Share options on ordinary shares granted June 1, 2026

Exercise price $0.76 per share Strike price for MDxHealth ordinary shares under the options

Expiration date May 28, 2036 Final expiration of the granted options

Post-grant derivative holdings 10,000 options Total options following this transaction

Ownership in Ahok BV 53.33% Hoffman’s interest in entity holding the options

Key Terms

Share Option, beneficially owned, pecuniary interest, annual general shareholders' meeting

4 terms

Share Option financial

"Represents options to purchase 10,000 ordinary shares of the Issuer"

beneficially owned financial

"may be deemed to be beneficially owned by the Reporting Person"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

pecuniary interest financial

"other than to the extent that he may have a pecuniary interest therein"

annual general shareholders' meeting financial

"vest in full on the date of the annual general shareholders' meeting"

A yearly meeting where a company’s shareholders and board of directors come together to review performance, vote on key issues (such as electing directors and approving auditors), and ask questions of management. Think of it like a town-hall or annual check-in where owners can influence how the company is run; outcomes can affect governance, dividend decisions and long-term strategy, all of which can influence the value and risks of an investor’s holdings.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/03/2026 - 05:30 PM Accepted by SEC EDGAR 06/03/2026 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoffman Koen

(Last) (First) (Middle)

CAP BUSINESS CENTER

ZONE INDUSTRIELLE DES HAUTS-SARTS

(Street)

HERSTAL BELGIUM 4040

(City) (State) (Zip)

BELGIUM

(Country)

2. Issuer Name and Ticker or Trading Symbol
MDxHealth SA [ MDXH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option	$0.76	06/01/2026		A		10,000		(1)	05/28/2036	Ordinary Shares	10,000	$0	10,000	I	By Ahok BV(2)

Explanation of Responses:

1. Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $0.76 granted on June 1, 2026 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted.

2. Share Options held by Ahok BV may be deemed to be beneficially owned by the Reporting Person as the owner of 53.33% of Ahok BV. The Reporting Person disclaims beneficial ownership of the securities held by Ahok BV other than to the extent that he may have a pecuniary interest therein.

	/s/ Mark Busch, as attorney-in-fact for Koen Hoffman	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MDxHealth (MDXH) report for Koen Hoffman?

MDxHealth reported a grant of 10,000 share options indirectly associated with director Koen Hoffman. The options allow purchase of ordinary shares at $0.76 each, reflecting a compensation award rather than an open-market share purchase or sale.

What are the key terms of Koen Hoffman’s MDxHealth share options?

The grant comprises 10,000 options on MDxHealth ordinary shares at an exercise price of $0.76 per share. These options expire on May 28, 2036 and vest fully at the annual general shareholders' meeting held in the year after the grant year.

How and when do Koen Hoffman’s MDxHealth options vest?

The 10,000 MDxHealth share options granted on June 1, 2026 vest in full on the date of the annual general shareholders' meeting held in the calendar year following the year of grant, creating a time-based vesting tied to a future shareholder meeting.

Are Koen Hoffman’s MDxHealth options held directly or through an entity?

The MDxHealth share options are held by Ahok BV, not directly by Koen Hoffman. He owns 53.33% of Ahok BV and may be deemed a beneficial owner, but he disclaims beneficial ownership beyond his pecuniary interest in the entity.

Does the MDxHealth Form 4 show any open-market share purchases or sales?

The Form 4 shows a grant of derivative securities, specifically 10,000 share options, and no open-market purchases or sales. This reflects a compensation-related award rather than trading activity in MDxHealth ordinary shares on the market.